免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / MY01 - An Aid for Diagnosing Acute Compartment Syndrome in Real Time

MY01 - An Aid for Diagnosing Acute Compartment Syndrome in Real Time

Study Description
Brief Summary:

Compartment syndrome can result from extremity trauma. It can also be caused by procedural cases that involve lower or upper extremity surgery. This condition results in muscle death, chronic pain, infection, and possible amputation. Early diagnosis is essential to institute interventions that can avoid complications. Subjective pain of the patient remains the mainstay for diagnosis. A method or device is needed that would improve our accuracy in diagnosing compartment syndrome. Ideally, this would be suited for single and/or continuous pressure read-outs. The aim is to reduce the incidence of missed compartment syndrome and diminish delays that would lead to significant disability.

Despite awareness, delayed diagnosis and treatment occurs in modern orthopaedic practice. As noted in many studies, once a diagnosis has been made, immediate fasciotomy is necessary to provide the best chance for a favourable clinical result. Therefore, there is a need for improved devices in order to obtain an early and reliable diagnosis.


Condition or disease Intervention/treatment Phase
Acute Compartment Syndrome Device: MY01 - Continuous Compartmental Pressure Monitor Not Applicable

Study Design
Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: MY01 - An Aid for Diagnosing Acute Compartment Syndrome in Real Time
Actual Study Start Date : July 17, 2020
Estimated Primary Completion Date : April 2021
Estimated Study Completion Date : May 2021
Arms and Interventions
Arm Intervention/treatment
Experimental: MY01 Device
Insertion of the MY01 device for up to 24 hours for continuous monitoring of compartment pressure
Device: MY01 - Continuous Compartmental Pressure Monitor
Insertion of the MY01 device for up to 24 hours for continuous monitoring of compartment pressure

Outcome Measures
Primary Outcome Measures :
  1. Clinical ease with which the new compartment pressure monitor was inserted into compartment. [ Time Frame: 24-48 hours following device insertion ]

    At device insertion, the physician will complete a feedback questionnaire, and routine assessment will be performed in compliance with the standard of care. As part of the feedback questionnaire, the physician will be asked to indicate on a sliding scale "How certain are you the device functioned adequately?" [0 = not confident] - [10 = very confident].

    The scale, administered part of a Clinical Report Form (CRF) titled 'Physician Survey', measures the physicians subjective level of certainty that the device sensor was inserted correctly within a patients muscle compartment. A record of 10 should be considered a very positive scenario, whereas a record of 0 should indicate a very negative scenario.


  2. Ability to monitor in real-time the continuous pressure read-out from the compartment in remote locations such as an I-phone. [ Time Frame: 24-48 hours following device insertion ]
    At device insertion, the physician will complete a feedback questionnaire, and routine assessment will be performed in compliance with the standard of care. As part of the feedback questionnaire, the physician will be asked to indicate in a Yes or No question "Did the MY01 Application remote data display work properly?" [Yes] or [No].

  3. The correlation of continuous pressure read-outs (high, normal or low) with clinical indications for compartment syndrome in each patient. [ Time Frame: 24-48 hours following device insertion, and again during the final follow-up of the participant approximately two weeks after treatment ]
    Routine assessments will be completed by healthcare personnel as per standard of care (the 6P's [Pain, Paraesthesia, Pallor, Paralysis, Pulselessness, Poikilothermia]), and compared against the pressure readout [mmHG] indicated by MY01's MicroElectroMechanical (MEMS) pressure sensor inserted at the afflicted location.


Secondary Outcome Measures :
  1. Correlation of clinical compartment syndrome release with data from the continuous pressure monitor read-out. [ Time Frame: 24-48 hours following device insertion, and again during the final follow-up of the participant approximately two weeks after treatment ]
    Should surgical fasciotomy be deemed necessary to release pent up pressure in the patients muscle compartment, the continuous pressure read-outs [mmHG] derived from the device will be compared against the timeframe when the decision to conduct fasciotomy was made.

  2. Short-term outcomes of the patient following continuous pressure monitoring [ Time Frame: 24-48 hours following device insertion. ]
    Survey and tabulation of data from patient clinical findings.


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Men or women, aged 18 years of age and older
  • Any tibial, foot, femoral, forearm or fracture that is felt by the surgeon to have a reasonable indication that elevated ICP could occur in the patient
  • Mentally fit to provide informed consent

Exclusion Criteria:

  • Patients with fractures that are not felt to be at risk of developing compartment syndrome based on serial clinical evaluation
  • Infected wounds; infected fractures
  • Patients who present with ACS requiring urgent surgical fasciotomy
  • Patients who cannot consent to trial
  • Pregnant women
Contacts and Locations

Contacts
Layout table for location contacts
Contact: Cooper Jefferson 7057902959 cooper.jefferson@nxtsens.com
Contact: Mary Amedeo (514) 934-1934 ext 43386 mary.amedeo@muhc.mcgill.ca

Locations
Layout table for location information
Canada, Quebec
Montreal General Hospital Recruiting
Montreal, Quebec, Canada, H3G 1A4
Contact: Mary Amedo    (514) 934-1934 ext 43386    mary.amedeo@muhc.mcgill.ca   
Principal Investigator: Dr. Mitchell Bernstein, MD         
Sub-Investigator: Dr. Rudolf Reindl, MD         
Sub-Investigator: Dr. Maxime Talbot, MD         
Hôpital du Sacré-Coeur de Montreal Not yet recruiting
Montreal, Quebec, Canada, H4J 1C5
Contact: Karine Tardif    514-338-2222 ext 3465    karinetardif2@gmail.com   
Contact: Julie Fournier    514-338-2222 ext 514-338-2222    fournier.julie77@gmail.com   
Sub-Investigator: Dr. Dominique Rouleau, MD         
Sub-Investigator: Dr. Yves Laflamme, MD         
Sponsors and Collaborators
MY01 Inc.
McGill University Health Centre/Research Institute of the McGill University Health Centre
Hopital du Sacre-Coeur de Montreal
Investigators
Layout table for investigator information
Principal Investigator: Mitchell Bernstein, MD Staff Surgeon, Orthopaedic Trauma & Limb Deformity, Montreal General Hospital | Assistant Professor Department of Surgery and Pediatric Surgery McGill University
Tracking Information
First Submitted Date  ICMJE July 3, 2019
First Posted Date  ICMJE July 11, 2019
Last Update Posted Date February 16, 2021
Actual Study Start Date  ICMJE July 17, 2020
Estimated Primary Completion Date April 2021   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: July 9, 2019)
  • Clinical ease with which the new compartment pressure monitor was inserted into compartment. [ Time Frame: 24-48 hours following device insertion ]
    At device insertion, the physician will complete a feedback questionnaire, and routine assessment will be performed in compliance with the standard of care. As part of the feedback questionnaire, the physician will be asked to indicate on a sliding scale "How certain are you the device functioned adequately?" [0 = not confident] - [10 = very confident]. The scale, administered part of a Clinical Report Form (CRF) titled 'Physician Survey', measures the physicians subjective level of certainty that the device sensor was inserted correctly within a patients muscle compartment. A record of 10 should be considered a very positive scenario, whereas a record of 0 should indicate a very negative scenario.
  • Ability to monitor in real-time the continuous pressure read-out from the compartment in remote locations such as an I-phone. [ Time Frame: 24-48 hours following device insertion ]
    At device insertion, the physician will complete a feedback questionnaire, and routine assessment will be performed in compliance with the standard of care. As part of the feedback questionnaire, the physician will be asked to indicate in a Yes or No question "Did the MY01 Application remote data display work properly?" [Yes] or [No].
  • The correlation of continuous pressure read-outs (high, normal or low) with clinical indications for compartment syndrome in each patient. [ Time Frame: 24-48 hours following device insertion, and again during the final follow-up of the participant approximately two weeks after treatment ]
    Routine assessments will be completed by healthcare personnel as per standard of care (the 6P's [Pain, Paraesthesia, Pallor, Paralysis, Pulselessness, Poikilothermia]), and compared against the pressure readout [mmHG] indicated by MY01's MicroElectroMechanical (MEMS) pressure sensor inserted at the afflicted location.
Original Primary Outcome Measures  ICMJE Same as current
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: July 9, 2019)
  • Correlation of clinical compartment syndrome release with data from the continuous pressure monitor read-out. [ Time Frame: 24-48 hours following device insertion, and again during the final follow-up of the participant approximately two weeks after treatment ]
    Should surgical fasciotomy be deemed necessary to release pent up pressure in the patients muscle compartment, the continuous pressure read-outs [mmHG] derived from the device will be compared against the timeframe when the decision to conduct fasciotomy was made.
  • Short-term outcomes of the patient following continuous pressure monitoring [ Time Frame: 24-48 hours following device insertion. ]
    Survey and tabulation of data from patient clinical findings.
Original Secondary Outcome Measures  ICMJE Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE MY01 - An Aid for Diagnosing Acute Compartment Syndrome in Real Time
Official Title  ICMJE MY01 - An Aid for Diagnosing Acute Compartment Syndrome in Real Time
Brief Summary

Compartment syndrome can result from extremity trauma. It can also be caused by procedural cases that involve lower or upper extremity surgery. This condition results in muscle death, chronic pain, infection, and possible amputation. Early diagnosis is essential to institute interventions that can avoid complications. Subjective pain of the patient remains the mainstay for diagnosis. A method or device is needed that would improve our accuracy in diagnosing compartment syndrome. Ideally, this would be suited for single and/or continuous pressure read-outs. The aim is to reduce the incidence of missed compartment syndrome and diminish delays that would lead to significant disability.

Despite awareness, delayed diagnosis and treatment occurs in modern orthopaedic practice. As noted in many studies, once a diagnosis has been made, immediate fasciotomy is necessary to provide the best chance for a favourable clinical result. Therefore, there is a need for improved devices in order to obtain an early and reliable diagnosis.

Detailed Description Not Provided
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
Condition  ICMJE Acute Compartment Syndrome
Intervention  ICMJE Device: MY01 - Continuous Compartmental Pressure Monitor
Insertion of the MY01 device for up to 24 hours for continuous monitoring of compartment pressure
Study Arms  ICMJE Experimental: MY01 Device
Insertion of the MY01 device for up to 24 hours for continuous monitoring of compartment pressure
Intervention: Device: MY01 - Continuous Compartmental Pressure Monitor
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Recruiting
Estimated Enrollment  ICMJE
 (submitted: July 9, 2019)
50
Original Estimated Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE May 2021
Estimated Primary Completion Date April 2021   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Men or women, aged 18 years of age and older
  • Any tibial, foot, femoral, forearm or fracture that is felt by the surgeon to have a reasonable indication that elevated ICP could occur in the patient
  • Mentally fit to provide informed consent

Exclusion Criteria:

  • Patients with fractures that are not felt to be at risk of developing compartment syndrome based on serial clinical evaluation
  • Infected wounds; infected fractures
  • Patients who present with ACS requiring urgent surgical fasciotomy
  • Patients who cannot consent to trial
  • Pregnant women
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years to 65 Years   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE
Contact: Cooper Jefferson 7057902959 cooper.jefferson@nxtsens.com
Contact: Mary Amedeo (514) 934-1934 ext 43386 mary.amedeo@muhc.mcgill.ca
Listed Location Countries  ICMJE Canada
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT04016103
Other Study ID Numbers  ICMJE MY01 - QC - 01
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: No
Responsible Party MY01 Inc.
Study Sponsor  ICMJE MY01 Inc.
Collaborators  ICMJE
  • McGill University Health Centre/Research Institute of the McGill University Health Centre
  • Hopital du Sacre-Coeur de Montreal
Investigators  ICMJE
Principal Investigator: Mitchell Bernstein, MD Staff Surgeon, Orthopaedic Trauma & Limb Deformity, Montreal General Hospital | Assistant Professor Department of Surgery and Pediatric Surgery McGill University
PRS Account MY01 Inc.
Verification Date February 2021

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP